SoftBank adds to shares in VTEX, YMM, cuts NMRA and exits DASH, among other moves
The Japanese investment holding company SoftBank Group ( OTCPK:SFTBY) purchased two new stakes: 20.45M shares in Pacific Biosciences of California ( PACB ), and 14.66M shares in Recursion ...
SoftBank reports new stakes in PacBio, Recursion Pharmaceuticals
SoftBank disclosed a 20.45M share position in PacBio (PACB) and 14.67M share position in Recursion Pharmaceuticals (RXRX) in a regulatory ...
SoftBank Group Q3 Earnings: Bad Timing For AI Exposure
SoftBank’s AI investments face increasing risks, especially in OpenAI and Stargate. Find out why SFTBF stock could be ...
SoftBank Group Leveraged to AI through Arm, Starlink and SoftBank Open AI Japan JV
1) The IPO and sell-down of the core Japanese telecom business. SoftBank sold around 36% of its shares of the core domestic telecom business in 2018 in an IPO, with the proceeds being used for ...
Softbank-Backed Arm Holdings 155% Post-IPO Surge Bolstered by AI Growth and Smartphone Integration
Arm Holdings' stock has surged 157% since its IPO, driven by AI potential, expansion in PC and AI markets, and licensing ...
Alphabet (NASDAQ:GOOGL) and SoftBank Bet on Quantum Computing Startup QuEra
Alphabet (GOOGL) is joining with OpenAI investor SoftBank (SFTBF) to back quantum computing startup QuEra, as part of a $230 ...
SoftBank Group Posts Quarterly Loss on Weak Tech Funds Business — Update
For its third quarter, SoftBank Group booked a net loss of 369.165 billion yen, equivalent to $2.42 billion, compared with a net profit of Y950.00 billion in the year-earlier period. That missed the ...